LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 70 of 166
Next
>>
>
1726 to 1750 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MDA-MB-231	XMD11-50	1.11	uM	LJP6	0.4724	0.0368	0.3530	0.0446
MDA-MB-231	XMD11-50	3.33	uM	LJP6	0.3681	0.0100	0.1890	0.0169
MDA-MB-231	XMD11-50	10	uM	LJP6	0.3029	0.0320	0.0699	0.0762
MDA-MB-231	XMD11-85h	0.04	uM	LJP6	0.7863	0.0284	0.7649	0.0269
MDA-MB-231	XMD11-85h	0.12	uM	LJP6	0.8912	0.0396	0.8843	0.0398
MDA-MB-231	XMD11-85h	0.37	uM	LJP6	0.8693	0.0391	0.8604	0.0395
MDA-MB-231	XMD11-85h	1.11	uM	LJP6	0.8461	0.0432	0.8339	0.0443
MDA-MB-231	XMD11-85h	3.33	uM	LJP6	0.7882	0.0508	0.7672	0.0535
MDA-MB-231	XMD11-85h	10	uM	LJP6	0.4427	0.0278	0.3078	0.0460
MDA-MB-231	XMD16-144	0.04	uM	LJP5	0.4485	0.0672	0.3148	0.1113
MDA-MB-231	XMD16-144	0.12	uM	LJP5	0.3270	0.0267	0.1235	0.0518
MDA-MB-231	XMD16-144	0.37	uM	LJP5	0.3334	0.0134	0.1363	0.0291
MDA-MB-231	XMD16-144	1.11	uM	LJP5	0.3295	0.0296	0.1278	0.0576
MDA-MB-231	XMD16-144	3.33	uM	LJP5	0.3072	0.0328	0.0868	0.0655
MDA-MB-231	XMD16-144	10	uM	LJP5	0.1910	0.0399	-0.1552	0.0932
MDA-MB-231	Erlotinib	0.04	uM	LJP5	0.9063	0.0308	0.9000	0.0332
MDA-MB-231	Erlotinib	0.12	uM	LJP5	0.9401	0.0169	0.9368	0.0185
MDA-MB-231	Erlotinib	0.37	uM	LJP5	0.9554	0.0187	0.9528	0.0203
MDA-MB-231	Erlotinib	1.11	uM	LJP5	0.9643	0.0190	0.9620	0.0206
MDA-MB-231	Erlotinib	3.33	uM	LJP5	0.9712	0.0083	0.9694	0.0092
MDA-MB-231	Erlotinib	10	uM	LJP5	0.6816	0.0333	0.6406	0.0399
MDA-MB-231	Gefitinib	0.04	uM	LJP6	1.0664	0.0391	1.0651	0.0362
MDA-MB-231	Gefitinib	0.12	uM	LJP6	1.0307	0.0399	1.0281	0.0390
MDA-MB-231	Gefitinib	0.37	uM	LJP6	1.0190	0.0064	1.0194	0.0057
MDA-MB-231	Gefitinib	1.11	uM	LJP6	1.0209	0.0229	1.0198	0.0222

|<
<<
Previous
Page 70 of 166
Next
>>
>
1726 to 1750 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)